인사이트
Insights From Our Experts
Articles
Behind the Breakthroughs and Practice-Changing Advances: Insights from ESMO 2024
Every year, the European Society for Medical Oncology (ESMO) brings together experts from pharma, research and advocacy organizations, and healthcare providers (HCPs) to hear about the year’s biggest oncology breakthroughs. With the theme “Shaping the Future…
The Evolving Landscape of HCP Engagement and the Role of Medical Information in This Era of Digital Innovation
This poster delves into the dynamic landscape of HCP engagement and the pivotal role of Medical Information (MI). It underscores the significance of effective HCP engagement for enhancing clinical decision-making and patient outcomes and emphasizes the…
Maximizing Medical Affairs and MSL Impact: How Choosing a Strategic Launch Partner Propels Success
Medical Science Liaisons (MSLs) serve as the bridge between pharmaceutical companies, healthcare professionals and the scientific community. Their impact reverberates across the entire healthcare ecosystem as they are essential for fostering scientific dialogue, driving evidence-based medicine…
Transforming the Future of Pharma Commercialization Through Medical Affairs
The pharmaceutical industry is rapidly evolving, and Medical Affairs is at the forefront of this transformation. As a clinician, it is an exciting time to think about the possibilities and how several emerging factors are…
Growing EVERSANA’s Value & Evidence Global Footprint with the Additions of Monique Martin, Pamela Vo and Deepika Thakur
EVERSANA’s Value and Evidence (V&E) team grew their global Health Economics & Outcomes Research (HEOR) leadership footprint in early 2024 with the addition of Monique Martin, Pamela Vo and Deepika Thakur, showcasing EVERSANA’s growing global life…
Pioneering the Path: How Medical Affairs is Charting the Course for Pre- and Post-Launch Strategies
Early involvement of Medical Affairs in the product lifecycle is not just beneficial – it is mission critical. In the swiftly changing realm of advanced therapies like biosimilars, rare disease molecules, and cell and gene therapies,…
Considerations for the Development of Interactive / Innovative Medical Information Content – Insights from a Service Provider
Posted by Michael DeLuca, PharmD, MBA, MSRA , Varun Pandey, PhD , Mary Mehrabian, PharmD, BCGP, BCMAS on 3월 7, 20243/7/24
The creation of high-quality, customer-centric medical information (MI) content accessible through various data dissemination channels is crucial. EVERSANA, a provider of global MI contact center services, has embarked on developing more interactive MI content. This initiative…
Current Trends in Medical Review of Promotional and Non-Promotional Materials
Posted by Michael DeLuca, PharmD, MBA, MSRA , Varun Pandey, PhD , Mary Mehrabian, PharmD, BCGP, BCMAS on 3월 7, 20243/7/24
Medical Information (MI) plays a crucial role in addressing inquiries from healthcare professionals, payors, and patients/caregivers and ensuring pharmaceutical products’ safe, effective, and appropriate use. However, MI teams often have other important responsibilities beyond the scope…
Future-Proofing Demands Proof: How Innovators Are Transforming Pharma Commercialization
In the fast-evolving landscape of pharmaceuticals, staying ahead demands more than just adapting to today’s challenges – it requires pioneering the future. Introducing intentional innovation, the sweet spot where blue-sky imagination meets on-the-ground effort. It’s being able…
Leveraging the Expertise of Medical Affairs to Create Global Value with Efficient, Cross-functional Collaboration
In the intricate world of pharmaceuticals, the role of Medical Affairs is paramount. Join us as we delve into the crucial elements that drive success in this pivotal function. From strategic alignment to robust data management…